E. Lau

M. Humbert, D. Amar, X. Jaïs, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Screening of Pulmonary Arterial Hypertension

D. Celermajer, A. Keogh, E. Lau, 2017, Seminars in Respiratory and Critical Care Medicine.

The 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: a practical chronicle of progress

M. Mcgoon, O. Sitbon, E. Lau, 2015, European Respiratory Journal.

M. Humbert, K. Stenmark, X. Jaïs, 2015 .

Pulmonary arterial hypertension with below threshold pulmonary vascular resistance

D. Celermajer, A. Keogh, E. Kotlyar, 2020, European Respiratory Journal.

Provocative testing of the pulmonary circulation: advances and unresolved issues

R. Naeije, E. Lau, 2016, European Respiratory Journal.

Resting pulmonary artery pressure of 21–24 mmHg predicts abnormal exercise haemodynamics

M. Humbert, D. Chemla, D. Celermajer, 2016, European Respiratory Journal.

Dead-space ventilation is linked to exercise capacity and survival in distal chronic thromboembolic pulmonary hypertension.

M. Humbert, X. Jaïs, L. Savale, 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Rare (pulmonary) disease day: “feeding the breath, energy for life!”

M. Humbert, S. Harari, V. Cottin, 2015, European Respiratory Journal.

Occupational exposure to organic solvents: a risk factor for pulmonary veno-occlusive disease

M. Humbert, E. Fadel, X. Jaïs, 2015, European Respiratory Journal.

Relation between left ventricular ejection time and pulmonary hemodynamics in pulmonary hypertension.

M. Humbert, D. Chemla, X. Jaïs, 2015, International journal of cardiology.

Screening for pulmonary arterial hypertension in adults carrying a BMPR2 mutation

M. Humbert, D. Chemla, X. Jaïs, 2020, European Respiratory Journal.

Rebuttal From Drs Humbert and Lau.

M. Humbert, E. Lau, 2019, Chest.

To stress or not to stress? Exercise pulmonary haemodynamic testing in systemic sclerosis

M. Humbert, P. Hervé, E. Lau, 2016, European Respiratory Journal.

Pulmonary veno-occlusive disease as an occupational lung disease.

M. Humbert, D. Montani, A. Descatha, 2017, The Lancet Respiratory Medicine.

Diagnostic concordance of different criteria for exercise pulmonary hypertension in subjects with normal resting pulmonary artery pressure

M. Humbert, D. Chemla, X. Jaïs, 2016, European Respiratory Journal.

Inherited Thrombophilia in Chinese CTEPH Patients

E. Lau, Katherine J. Kearney, 2022, JACC. Asia.

The emerging role of the contractile and vascular reserves in pulmonary arterial hypertension

D. Celermajer, R. Naeije, E. Lau, 2015, European Respiratory Journal.

Response to Letter Regarding Article, "Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension".

M. Humbert, X. Jaïs, G. Simonneau, 2015, Circulation.

Acute Vasoreactivity Testing and Outcomes in Pulmonary Arterial Hypertension: A Call for Increased Testing.

R. Weintraub, A. Keogh, P. Steele, 2022, Heart, lung & circulation.

An official European Respiratory Society statement: pulmonary haemodynamics during exercise

M. Humbert, J. Barberà, S. Rosenkranz, 2017, European Respiratory Journal.

Advances in Therapeutic Interventions for Patients With Pulmonary Arterial Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2014, Circulation.

Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.

M. Humbert, D. Amar, E. Fadel, 2017, The Lancet. Respiratory medicine.

Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound

D. Celermajer, M. Adams, E. Lau, 2012, PloS one.

Influence of critical closing pressure on systemic vascular resistance and total arterial compliance: A clinical invasive study.

D. Chemla, M. Brahimi, A. Nitenberg, 2017, Archives of cardiovascular diseases.

Epidemiology and treatment of pulmonary arterial hypertension

M. Humbert, E. Giannoulatou, D. Celermajer, 2017, Nature Reviews Cardiology.

Pulmonary vascular resistance and compliance relationship in pulmonary hypertension

D. Chemla, Y. Papelier, P. Hervé, 2015, European Respiratory Journal.

P100 Quality of home spirometry performance amongst adults with cystic fibrosis

E. Lau, H. Jo, S. Sivam, 2021, Journal of Cystic Fibrosis.

Pathophysiology of exercise intolerance in pulmonary arterial hypertension

G. Davis, D. Celermajer, R. Cordina, 2018, Respirology.

Inspiratory Muscle Training Improves Inspiratory Muscle Strength and Functional Exercise Capacity in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: A Pilot Randomised Controlled Study.

G. Davis, J. Alison, D. Celermajer, 2020, Heart, lung & circulation.

INSPIRATORY MUSCLE TRAINING IMPROVES SIX-MINUTE WALK DISTANCE IN ADULTS WITH PULMONARY ARTERIAL HYPERTENSION

G. Davis, J. Alison, D. Celermajer, 2020 .

Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea.

D. Celermajer, K. Melehan, B. Yee, 2013, International journal of cardiology.

Management and Therapy for Pulmonary Hypertension : 2016 Update

M. Humbert, E. Lau, S. Visser, 2017 .

Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registry

R. Weintraub, D. Celermajer, A. Keogh, 2020, Respirology.

Right heart function during simulated altitude in patients with pulmonary arterial hypertension

Wei Zhao, L. Kritharides, M. Peters, 2017, Open Heart.

Pulmonary Hypertension Definition, Classification, and Epidemiology in Asia

E. Lau, James J. Anderson, 2022, JACC. Asia.

Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and Challenges.

R. Weintraub, D. Celermajer, A. Keogh, 2020, Heart, lung & circulation.

β3 adrenergic agonism: A novel pathway which improves right ventricular‐pulmonary arterial hemodynamics in pulmonary arterial hypertension

L. Quek, G. Figtree, D. Celermajer, 2023, Physiological reports.

Survival outcomes in severe congenital versus non-congenital pulmonary hypertension

D. Celermajer, C. Arnott, E. Lau, 2016, Heart Asia.

Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?

D. Celermajer, T. Corte, R. Cordina, 2017, Internal medicine journal.

Criteria for diagnosis of exercise pulmonary hypertension

M. Humbert, D. Chemla, X. Jaïs, 2015, European Respiratory Journal.

Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.

R. Weintraub, R. Benza, D. Celermajer, 2019, Chest.

Patent foramen ovale and obstructive sleep apnea: a new association?

D. Celermajer, B. Yee, R. Grunstein, 2010, Sleep medicine reviews.

POINT: Should Initial Combination Therapy Be the Standard of Care in Pulmonary Arterial Hypertension? Yes.

M. Humbert, E. Lau, 2019, Chest.

Respiratory effects of trichloroethylene.

M. Humbert, F. Perros, D. Montani, 2018, Respiratory medicine.

Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New Zealand.

E. Giannoulatou, D. Celermajer, A. Keogh, 2017, Heart, lung & circulation.

Are indexed values better for defining exercise pulmonary hypertension?

M. Humbert, D. Chemla, X. Jaïs, 2017, European Respiratory Journal.

The isobaric pulmonary arterial compliance in pulmonary hypertension

M. Humbert, D. Chemla, L. Savale, 2021, ERJ Open Research.

Clinical and Hemodynamic Correlates of Pulmonary Arterial Stiffness in Incident, Untreated Patients With Idiopathic Pulmonary Arterial Hypertension

M. Humbert, D. Chemla, X. Jaïs, 2018, Chest.

Golden Ratio and the Proportionality Between Pulmonary Pressure Components in Pulmonary Arterial Hypertension

M. Humbert, E. Fadel, D. Chemla, 2019, Chest.

Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study

B. Toelle, G. Marks, D. Celermajer, 2013, European Respiratory Journal.

Pulmonary arterial compliance: a physiological variable still searching for clinical relevance?

E. Lau, K. Kearney, 2023, Heart.

Usefulness of Cardiovascular Magnetic Resonance Indices to Rule In or Rule Out Precapillary Pulmonary Hypertension.

M. Humbert, C. Rochitte, D. Chemla, 2015, The Canadian journal of cardiology.

Treatment responsiveness in pulmonary arterial hypertension--preliminary report on serial intra-arterial Doppler flow velocity waveform measurements.

D. Celermajer, E. Lau, R. Ilsar, 2011, International Journal of Cardiology.

Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension

C. Hayward, E. Kotlyar, A. Jabbour, 2023, ESC heart failure.

Understanding the Similarities and Differences between Hepatic and Pulmonary Veno-Occlusive Disease.

M. Humbert, D. Valla, B. Girerd, 2019, The American journal of pathology.

Characteristic changes to pulsatile and steady‐state load according to pulmonary hypertension classification

E. Kotlyar, A. Jabbour, E. Lau, 2023, Physiological reports.

Impact of left heart disease risk factors on risk stratification and treatment response in pulmonary arterial hypertension

R. Weintraub, R. Cordina, A. Keogh, 2021, European Heart Journal.

Recent Advances in Pulmonary Hypertension

M. Humbert, X. Jaïs, G. Simonneau, 2014 .

Pulmonary hypertension: what you need to know

E. Lau, A. Moonen, V. Thakkar, 2018 .

Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective

M. Humbert, E. Lau, 2020, American journal of respiratory and critical care medicine.